Alverine Citrate - CAS 5560-59-8
Catalog: |
BB029109 |
Product Name: |
Alverine Citrate |
CAS: |
5560-59-8 |
Synonyms: |
N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid |
Application: |
Parasympatholytics |
Related CAS: | 5982-87-6 (HCl)
|
IUPAC Name: | N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid |
Description: | Alverine Citrate is a highly potent competitive CXCR4 antagonist with EC50 of 0.3 nM. |
Molecular Weight: | 473.56 |
Molecular Formula: | C20H27N · C6H8O7 |
Canonical SMILES: | CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
InChI: | InChI=1S/C20H27N.C6H8O7/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-8,11-14H,2,9-10,15-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) |
InChI Key: | RYHCACJBKCOBTJ-UHFFFAOYSA-N |
Boiling Point: | 358.8 °C at 760 mmHg |
Purity: | > 98 % |
Appearance: | Solid powder |
MDL: | MFCD00035086 |
LogP: | 3.32540 |
GHS Hazard Statement: | H301 (25%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P301+P312, P302+P352, P304+P312, P304+P340, P312, P321, P322, P330, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
RU-2744125-C1 | Medication for functional gastrointestinal disorders | 20200416 |
KR-102186564-B1 | Composition for preventing or treating muscle weakness diseases comprising alverine, 4-hydroxy alverine or pharmaceutically acceptable salts thereof | 20200409 |
WO-2021206513-A1 | Pharmaceutical composition for preventing or treating muscular weakness-related diseases comprising alverine, 4-hydroxy alverine, derivative thereof, or pharmaceutically acceptable salt thereof | 20200409 |
WO-2021133904-A1 | Solid dosage forms containing bacteria and microbial extracellular vesicles | 20191227 |
CN-211024149-U | Production of citric acid alverine capsule is with suppression sealing device | 20191012 |
PMID | Publication Date | Title | Journal |
23571415 | 20130601 | Structure-based identification of OATP1B1/3 inhibitors | Molecular pharmacology |
21979395 | 20110901 | Inclusion of a spasmolytic in bowel cleansing: a prospective randomized study | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates |
20564607 | 20100601 | A rapid and most sensitive liquid chromatography/tandem mass spectrometry method for simultaneous determination of alverine and its major metabolite, para hydroxy alverine, in human plasma: application to a pharmacokinetic and bioequivalence study | Drug testing and analysis |
20415841 | 20100401 | Alverine citrate, simeticone, and Rome III irritable bowel syndrome | Alimentary pharmacology & therapeutics |
20003095 | 20100301 | Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study | Alimentary pharmacology & therapeutics |
Complexity: | 442 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 473.24135246 |
Formal Charge: | 0 |
Heavy Atom Count: | 34 |
Hydrogen Bond Acceptor Count: | 8 |
Hydrogen Bond Donor Count: | 4 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 473.24135246 |
Rotatable Bond Count: | 14 |
Topological Polar Surface Area: | 135 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
-
[891016-02-7]
ML-SI3
-
[100644-65-3]
6-Amino-4-chloro-1H-pyrazolo[3,4-d]pyrimidine
-
[730-46-1]
5-Dodecyldihydro-2(3H)-Furanone
-
[144222-34-4]
(1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine
-
[119-24-4]
Folic Acid EP Impurity D (Methotrexate EP Impurity D)
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
INDUSTRY LEADERS TRUST OUR PRODUCTS